A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO2TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE Article

Full Text via DOI: 10.1093/neuonc/noae165.0397 Web of Science: 001362566100021

Cited authors

  • Badruddoja MA, Placencia C, Unger E, Gellert S, Stea B, Peters KB, Kong XT, Aiken R, Goldin C, Mahadevan D, Goldlust SA

Publication date

  • 2024

Published in

International Standard Serial Number (ISSN)

  • 1522-8517

Number of pages

  • 1

Volume

  • 26